Company Details
pharmaceutics-international
354
10,409
3254
pharm-int.com
0
PII_3049995
In-progress

Pii, A Jabil Company Company CyberSecurity Posture
pharm-int.comPharmaceutics International Inc. (Pii) is a leading Contract Development and Manufacturing Organization (CDMO) that provides comprehensive solutions for aseptic and oral dosage forms. Founded in 1994 by Dr. Syed Abidi, a pioneering formulation scientist, Pii has over 30 years of experience handling complex formulations, potent compounds, and controlled substances. Based in Hunt Valley, MD, Pii’s capabilities include lyophilization, high potency isolation, and robotic filling. Our expert teams ensure the highest quality and safety standards, supporting small to medium-volume projects with scalable solutions and unmatched flexibility. Committed to client-centric drug development, Pii's mission is to enhance quality of life through innovative and high-quality pharmaceuticals. Discover more about our services and how we can support your projects at www.pharm-int.com.
Company Details
pharmaceutics-international
354
10,409
3254
pharm-int.com
0
PII_3049995
In-progress
Between 650 and 699

PJC Global Score (TPRM)XXXX

Description: **Pharmaceutics International, Inc. Reports Major Data Breach Exposing Sensitive PII** Pharmaceutics International, Inc. (Pii), a prominent contract development and manufacturing organization in the pharmaceutical sector, has disclosed a significant data breach involving highly sensitive personally identifiable information (PII). The incident was reported to the Massachusetts Attorney General’s office on **December 23, 2025**, with at least **five Massachusetts residents confirmed impacted**—though the total number of affected individuals may rise as the investigation continues. The breach exposed a broad range of personal data, including **full names, Social Security numbers, dates of birth, current and former addresses, government-issued IDs, Social Security cards, pay stubs, and W-2 forms**. The scope of the exposed information heightens the risk of **identity theft and financial fraud**, though the company has not yet identified the attack vector or responsible threat actor. In response, Pii **secured its systems, initiated a comprehensive incident review, and is reassessing its security protocols** to prevent future breaches. Regulatory notifications have been filed as required by law. Affected individuals are being offered **complimentary credit monitoring and identity protection services through Kroll**, along with a dedicated call center for inquiries (**844-354-1388**, Monday–Friday, 9 a.m.–6:30 p.m. ET). The investigation remains ongoing, with no further details on the breach’s origin or potential broader impact.


Pii, A Jabil Company has 8.7% more incidents than the average of same-industry companies with at least one recorded incident.
Pii, A Jabil Company has 28.21% more incidents than the average of all companies with at least one recorded incident.
Pii, A Jabil Company reported 1 incidents this year: 0 cyber attacks, 0 ransomware, 0 vulnerabilities, 1 data breaches, compared to industry peers with at least 1 incident.
PJC cyber incidents detection timeline including parent company and subsidiaries

Pharmaceutics International Inc. (Pii) is a leading Contract Development and Manufacturing Organization (CDMO) that provides comprehensive solutions for aseptic and oral dosage forms. Founded in 1994 by Dr. Syed Abidi, a pioneering formulation scientist, Pii has over 30 years of experience handling complex formulations, potent compounds, and controlled substances. Based in Hunt Valley, MD, Pii’s capabilities include lyophilization, high potency isolation, and robotic filling. Our expert teams ensure the highest quality and safety standards, supporting small to medium-volume projects with scalable solutions and unmatched flexibility. Committed to client-centric drug development, Pii's mission is to enhance quality of life through innovative and high-quality pharmaceuticals. Discover more about our services and how we can support your projects at www.pharm-int.com.


At Janssen, we never stop working toward a future where disease is a thing of the past. We’re the Pharmaceutical Companies of Johnson & Johnson, and you can count on us to keep working tirelessly to make that future a reality for patients everywhere, by fighting sickness with science, improving ac
For almost 50 years, we’ve been creating high-quality medicines and making them accessible to the people who need them. We are a trusted, reliable partner and dependable source of over 800* high-quality generic, specialty and branded pharmaceutical products that hospitals, physicians and pharmacists

At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccine

Cipla is a leading global pharmaceutical company trusted by healthcare professionals and patients across the world since 1935. A compassionate approach to healthcare that goes beyond the pursuit of profit and growth has been the force impelling Cipla’s history over the years. Our credo and our purp

At MSD, known as Merck & Co., Inc., Rahway, NJ, USA in the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important

Founded to serve health 70 years ago, Servier is a global pharmaceutical group governed by a non-profit Foundation that aspires to make a meaningful social impact for patients and for a sustainable world. The Group’s unique governance model preserves its independence and means it can fully serve its
Novartis is an innovative medicines company. Every day, working to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide. Find out mor

Hetero is a research based global pharmaceutical company focused on development, manufacturing and marketing of Active Pharmaceutical Ingredients (APIs), Intermediate Chemicals & Finished Dosages. Ever since its establishment in 1993, Hetero showed a tradition of excellence and deep sense of commitm

We're a medicine company turning science into healing to make life better for people around the world. It all started nearly 150 years ago with a clear vision from founder Colonel Eli Lilly: "Take what you find here and make it better and better." Harnessing the power of biotechnology, chemistry and
.png)
Jabil has acquired contract development and manufacturing organisation (CDMO) Pharmaceutics International (Pii) to offer support for drug development customers.

Explore insights on cybersecurity incidents, risk posture, and Rankiteo's assessments.
The official website of Pii, A Jabil Company is http://www.pharm-int.com.
According to Rankiteo, Pii, A Jabil Company’s AI-generated cybersecurity score is 689, reflecting their Weak security posture.
According to Rankiteo, Pii, A Jabil Company currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.
According to Rankiteo, Pii, A Jabil Company is not certified under SOC 2 Type 1.
According to Rankiteo, Pii, A Jabil Company does not hold a SOC 2 Type 2 certification.
According to Rankiteo, Pii, A Jabil Company is not listed as GDPR compliant.
According to Rankiteo, Pii, A Jabil Company does not currently maintain PCI DSS compliance.
According to Rankiteo, Pii, A Jabil Company is not compliant with HIPAA regulations.
According to Rankiteo,Pii, A Jabil Company is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.
Pii, A Jabil Company operates primarily in the Pharmaceutical Manufacturing industry.
Pii, A Jabil Company employs approximately 354 people worldwide.
Pii, A Jabil Company presently has no subsidiaries across any sectors.
Pii, A Jabil Company’s official LinkedIn profile has approximately 10,409 followers.
Pii, A Jabil Company is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.
Yes, Pii, A Jabil Company has an official profile on Crunchbase, which can be accessed here: https://www.crunchbase.com/organization/pharmaceutics-international.
Yes, Pii, A Jabil Company maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/pharmaceutics-international.
As of December 24, 2025, Rankiteo reports that Pii, A Jabil Company has experienced 1 cybersecurity incidents.
Pii, A Jabil Company has an estimated 5,462 peer or competitor companies worldwide.
Incident Types: The types of cybersecurity incidents that have occurred include Breach.
Detection and Response: The company detects and responds to cybersecurity incidents through an incident response plan activated with yes, and third party assistance with kroll (credit monitoring and identity protection services), and containment measures with secured systems, and remediation measures with reviewed security policies and procedures; assessing security measures to reduce future risks, and communication strategy with notification to affected individuals; call center established..
Title: Pharmaceutics International, Inc. Data Breach
Description: Pharmaceutics International, Inc., a leading contract development and manufacturing organization in the pharmaceutical industry, recently disclosed a significant data breach involving sensitive personally identifiable information (PII). The breach exposed a wide range of sensitive information, including full names, Social Security numbers, dates of birth, current and previous addresses, government-issued identification cards, Social Security cards, pay stubs and W2 forms.
Date Publicly Disclosed: 2025-12-23
Type: Data Breach
Common Attack Types: The most common types of attacks the company has faced is Breach.

Data Compromised: Sensitive personally identifiable information (PII)
Identity Theft Risk: High
Commonly Compromised Data Types: The types of data most commonly compromised in incidents are Personally Identifiable Information (PII).

Entity Name: Pharmaceutics International, Inc.
Entity Type: Contract Development and Manufacturing Organization (CDMO)
Industry: Pharmaceutical
Customers Affected: At least 5 residents of Massachusetts (number subject to change)

Incident Response Plan Activated: Yes
Third Party Assistance: Kroll (credit monitoring and identity protection services)
Containment Measures: Secured systems
Remediation Measures: Reviewed security policies and procedures; assessing security measures to reduce future risks
Communication Strategy: Notification to affected individuals; call center established
Incident Response Plan: The company's incident response plan is described as Yes.
Third-Party Assistance: The company involves third-party assistance in incident response through Kroll (credit monitoring and identity protection services).

Type of Data Compromised: Personally Identifiable Information (PII)
Sensitivity of Data: High
File Types Exposed: Government-issued identification cardsSocial Security cardsPay stubsW2 forms
Personally Identifiable Information: Full namesSocial Security numbersDates of birthCurrent and previous addresses
Prevention of Data Exfiltration: The company takes the following measures to prevent data exfiltration: Reviewed security policies and procedures; assessing security measures to reduce future risks.
Handling of PII Incidents: The company handles incidents involving personally identifiable information (PII) through by secured systems.

Regulatory Notifications: Yes (relevant regulators notified as required by law)

Recommendations: Sign up for free Kroll credit monitoring and identity theft protection services, Monitor credit reports and financial accounts for unusual activity, Be alert for phishing emails or phone calls using exposed information, Consider placing a fraud alert or credit freeze with major credit bureausSign up for free Kroll credit monitoring and identity theft protection services, Monitor credit reports and financial accounts for unusual activity, Be alert for phishing emails or phone calls using exposed information, Consider placing a fraud alert or credit freeze with major credit bureausSign up for free Kroll credit monitoring and identity theft protection services, Monitor credit reports and financial accounts for unusual activity, Be alert for phishing emails or phone calls using exposed information, Consider placing a fraud alert or credit freeze with major credit bureausSign up for free Kroll credit monitoring and identity theft protection services, Monitor credit reports and financial accounts for unusual activity, Be alert for phishing emails or phone calls using exposed information, Consider placing a fraud alert or credit freeze with major credit bureaus

Source: Massachusetts Attorney General’s office
Additional Resources: Stakeholders can find additional resources on cybersecurity best practices at and Source: Massachusetts Attorney General’s office.

Investigation Status: Ongoing
Communication of Investigation Status: The company communicates the status of incident investigations to stakeholders through Notification to affected individuals; call center established.

Customer Advisories: Call center established at 844-354-1388 (Monday through Friday, 9 a.m. to 6:30 p.m. ET)
Advisories Provided: The company provides the following advisories to stakeholders and customers following an incident: were Call center established at 844-354-1388 (Monday through Friday and 9 a.m. to 6:30 p.m. ET).

Corrective Actions: Assessing security measures to reduce the risk of similar events in the future
Post-Incident Analysis Process: The company's process for conducting post-incident analysis is described as Kroll (credit monitoring and identity protection services).
Corrective Actions Taken: The company has taken the following corrective actions based on post-incident analysis: Assessing security measures to reduce the risk of similar events in the future.
Most Recent Incident Publicly Disclosed: The most recent incident publicly disclosed was on 2025-12-23.
Most Significant Data Compromised: The most significant data compromised in an incident was Sensitive personally identifiable information (PII).
Third-Party Assistance in Most Recent Incident: The third-party assistance involved in the most recent incident was Kroll (credit monitoring and identity protection services).
Containment Measures in Most Recent Incident: The containment measures taken in the most recent incident was Secured systems.
Most Sensitive Data Compromised: The most sensitive data compromised in a breach was Sensitive personally identifiable information (PII).
Most Significant Recommendation Implemented: The most significant recommendation implemented to improve cybersecurity was Monitor credit reports and financial accounts for unusual activity, Be alert for phishing emails or phone calls using exposed information, Consider placing a fraud alert or credit freeze with major credit bureaus and Sign up for free Kroll credit monitoring and identity theft protection services.
Most Recent Source: The most recent source of information about an incident is Massachusetts Attorney General’s office.
Current Status of Most Recent Investigation: The current status of the most recent investigation is Ongoing.
Most Recent Customer Advisory: The most recent customer advisory issued were an Call center established at 844-354-1388 (Monday through Friday and 9 a.m. to 6:30 p.m. ET).
.png)
Marshmallow is a lightweight library for converting complex objects to and from simple Python datatypes. In versions from 3.0.0rc1 to before 3.26.2 and from 4.0.0 to before 4.1.2, Schema.load(data, many=True) is vulnerable to denial of service attacks. A moderately sized request can consume a disproportionate amount of CPU time. This issue has been patched in version 3.26.2 and 4.1.2.
KEDA is a Kubernetes-based Event Driven Autoscaling component. Prior to versions 2.17.3 and 2.18.3, an Arbitrary File Read vulnerability has been identified in KEDA, potentially affecting any KEDA resource that uses TriggerAuthentication to configure HashiCorp Vault authentication. The vulnerability stems from an incorrect or insufficient path validation when loading the Service Account Token specified in spec.hashiCorpVault.credential.serviceAccount. An attacker with permissions to create or modify a TriggerAuthentication resource can exfiltrate the content of any file from the node's filesystem (where the KEDA pod resides) by directing the file's content to a server under their control, as part of the Vault authentication request. The potential impact includes the exfiltration of sensitive system information, such as secrets, keys, or the content of files like /etc/passwd. This issue has been patched in versions 2.17.3 and 2.18.3.
Fedify is a TypeScript library for building federated server apps powered by ActivityPub. Prior to versions 1.6.13, 1.7.14, 1.8.15, and 1.9.2, a Regular Expression Denial of Service (ReDoS) vulnerability exists in Fedify's document loader. The HTML parsing regex at packages/fedify/src/runtime/docloader.ts:259 contains nested quantifiers that cause catastrophic backtracking when processing maliciously crafted HTML responses. This issue has been patched in versions 1.6.13, 1.7.14, 1.8.15, and 1.9.2.
Authenticated Remote Code Execution (RCE) in PluXml CMS 5.8.22 allows an attacker with administrator panel access to inject a malicious PHP webshell into a theme file (e.g., home.php).
An issue was discovered in Xiongmai XM530 IP cameras on firmware V5.00.R02.000807D8.10010.346624.S.ONVIF 21.06. The GetStreamUri exposes RTSP URIs containing hardcoded credentials enabling direct unauthorized video stream access.

Get company history
Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.
Identify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.
Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.
Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.
Leverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.